Aortic remodeling after endovascular treatment of complicated type B aortic dissection with the use of a composite device design

Joseph V. Lombardi, Richard P. Cambria, Christoph A. Nienaber, Roberto Chiesa, Peter Mossop, Stéphan Haulon, Qing Zhou, Feiyi Jia

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Objective The purpose of this study is to report updated clinical and aortic remodeling results from the Study for the Treatment of complicated Type B Aortic Dissection using Endoluminal repair (STABLE) trial, a prospective, multicenter study evaluating safety and effectiveness of a pathology-specific endovascular system (proximal stent graft and distal bare metal stent) for the treatment of complicated type B aortic dissection. Methods All 86 enrolled patients (mean age, 59 years; 73.3% men) were treated within 90 days of symptom onset (55 with acute dissections and 31 with nonacute dissections). Inclusion criteria were branch vessel obstruction/compromise, impending rupture as evidenced by periaortic effusion/hematoma, resistant hypertension, persistent pain/symptoms, or aortic growth ≥5 mm within 3 months (or transaortic diameter ≥40 mm). Remodeling of the dissected aorta, including thrombosis of the false lumen and changes in the true lumen, false lumen, and transaortic diameter, were assessed in patients with available computed tomographic imaging through 2 years. Results The 30-day mortality rate was 4.7% (4/86) in the overall patient group (5.5% in acute patients and 3.2% in non-acute patients). Freedom from all-cause mortality was 88.3% at 1 year and 84.7% at 2 years (no significant difference between acute and nonacute patients). From baseline to 2 years, the true lumen diameter increased significantly in the descending thoracic aorta and the more distal abdominal aorta, along with a decrease in the false lumen diameter in both aortic segments. A majority of patients had either a stable or shrinking transaortic diameter in the thoracic (80.3% at 1 year and 73.9% at 2 years) or abdominal aorta (79.1% at 1 year and 66.7% at 2 years). Transaortic growth (>5 mm) occurred predominantly in acute dissections. Consistently, a shorter time from symptom onset to treatment was found to predict transaortic growth in the abdominal aorta (P =.03). Conclusions Endovascular repair of complicated type B aortic dissection with the use of a composite construct demonstrates favorable early clinical outcomes and aortic remodeling. However, patients treated in the acute setting may be prone to aortic growth and may require close observation. Follow-up through 5 years is ongoing.

Original languageEnglish
Pages (from-to)1544-1554
Number of pages11
JournalJournal of Vascular Surgery
Volume59
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

Equipment Design
Dissection
Abdominal Aorta
Therapeutics
Growth
Thoracic Aorta
Stents
Mortality
Angioplasty
Hematoma
Multicenter Studies
Aorta
Rupture
Thrombosis
Thorax
Metals
Observation
Prospective Studies
Pathology
Hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Aortic remodeling after endovascular treatment of complicated type B aortic dissection with the use of a composite device design. / Lombardi, Joseph V.; Cambria, Richard P.; Nienaber, Christoph A.; Chiesa, Roberto; Mossop, Peter; Haulon, Stéphan; Zhou, Qing; Jia, Feiyi.

In: Journal of Vascular Surgery, Vol. 59, No. 6, 2014, p. 1544-1554.

Research output: Contribution to journalArticle

Lombardi, Joseph V. ; Cambria, Richard P. ; Nienaber, Christoph A. ; Chiesa, Roberto ; Mossop, Peter ; Haulon, Stéphan ; Zhou, Qing ; Jia, Feiyi. / Aortic remodeling after endovascular treatment of complicated type B aortic dissection with the use of a composite device design. In: Journal of Vascular Surgery. 2014 ; Vol. 59, No. 6. pp. 1544-1554.
@article{68235739647345f1a4b7de0cce5faa25,
title = "Aortic remodeling after endovascular treatment of complicated type B aortic dissection with the use of a composite device design",
abstract = "Objective The purpose of this study is to report updated clinical and aortic remodeling results from the Study for the Treatment of complicated Type B Aortic Dissection using Endoluminal repair (STABLE) trial, a prospective, multicenter study evaluating safety and effectiveness of a pathology-specific endovascular system (proximal stent graft and distal bare metal stent) for the treatment of complicated type B aortic dissection. Methods All 86 enrolled patients (mean age, 59 years; 73.3{\%} men) were treated within 90 days of symptom onset (55 with acute dissections and 31 with nonacute dissections). Inclusion criteria were branch vessel obstruction/compromise, impending rupture as evidenced by periaortic effusion/hematoma, resistant hypertension, persistent pain/symptoms, or aortic growth ≥5 mm within 3 months (or transaortic diameter ≥40 mm). Remodeling of the dissected aorta, including thrombosis of the false lumen and changes in the true lumen, false lumen, and transaortic diameter, were assessed in patients with available computed tomographic imaging through 2 years. Results The 30-day mortality rate was 4.7{\%} (4/86) in the overall patient group (5.5{\%} in acute patients and 3.2{\%} in non-acute patients). Freedom from all-cause mortality was 88.3{\%} at 1 year and 84.7{\%} at 2 years (no significant difference between acute and nonacute patients). From baseline to 2 years, the true lumen diameter increased significantly in the descending thoracic aorta and the more distal abdominal aorta, along with a decrease in the false lumen diameter in both aortic segments. A majority of patients had either a stable or shrinking transaortic diameter in the thoracic (80.3{\%} at 1 year and 73.9{\%} at 2 years) or abdominal aorta (79.1{\%} at 1 year and 66.7{\%} at 2 years). Transaortic growth (>5 mm) occurred predominantly in acute dissections. Consistently, a shorter time from symptom onset to treatment was found to predict transaortic growth in the abdominal aorta (P =.03). Conclusions Endovascular repair of complicated type B aortic dissection with the use of a composite construct demonstrates favorable early clinical outcomes and aortic remodeling. However, patients treated in the acute setting may be prone to aortic growth and may require close observation. Follow-up through 5 years is ongoing.",
author = "Lombardi, {Joseph V.} and Cambria, {Richard P.} and Nienaber, {Christoph A.} and Roberto Chiesa and Peter Mossop and St{\'e}phan Haulon and Qing Zhou and Feiyi Jia",
year = "2014",
doi = "10.1016/j.jvs.2013.12.038",
language = "English",
volume = "59",
pages = "1544--1554",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Aortic remodeling after endovascular treatment of complicated type B aortic dissection with the use of a composite device design

AU - Lombardi, Joseph V.

AU - Cambria, Richard P.

AU - Nienaber, Christoph A.

AU - Chiesa, Roberto

AU - Mossop, Peter

AU - Haulon, Stéphan

AU - Zhou, Qing

AU - Jia, Feiyi

PY - 2014

Y1 - 2014

N2 - Objective The purpose of this study is to report updated clinical and aortic remodeling results from the Study for the Treatment of complicated Type B Aortic Dissection using Endoluminal repair (STABLE) trial, a prospective, multicenter study evaluating safety and effectiveness of a pathology-specific endovascular system (proximal stent graft and distal bare metal stent) for the treatment of complicated type B aortic dissection. Methods All 86 enrolled patients (mean age, 59 years; 73.3% men) were treated within 90 days of symptom onset (55 with acute dissections and 31 with nonacute dissections). Inclusion criteria were branch vessel obstruction/compromise, impending rupture as evidenced by periaortic effusion/hematoma, resistant hypertension, persistent pain/symptoms, or aortic growth ≥5 mm within 3 months (or transaortic diameter ≥40 mm). Remodeling of the dissected aorta, including thrombosis of the false lumen and changes in the true lumen, false lumen, and transaortic diameter, were assessed in patients with available computed tomographic imaging through 2 years. Results The 30-day mortality rate was 4.7% (4/86) in the overall patient group (5.5% in acute patients and 3.2% in non-acute patients). Freedom from all-cause mortality was 88.3% at 1 year and 84.7% at 2 years (no significant difference between acute and nonacute patients). From baseline to 2 years, the true lumen diameter increased significantly in the descending thoracic aorta and the more distal abdominal aorta, along with a decrease in the false lumen diameter in both aortic segments. A majority of patients had either a stable or shrinking transaortic diameter in the thoracic (80.3% at 1 year and 73.9% at 2 years) or abdominal aorta (79.1% at 1 year and 66.7% at 2 years). Transaortic growth (>5 mm) occurred predominantly in acute dissections. Consistently, a shorter time from symptom onset to treatment was found to predict transaortic growth in the abdominal aorta (P =.03). Conclusions Endovascular repair of complicated type B aortic dissection with the use of a composite construct demonstrates favorable early clinical outcomes and aortic remodeling. However, patients treated in the acute setting may be prone to aortic growth and may require close observation. Follow-up through 5 years is ongoing.

AB - Objective The purpose of this study is to report updated clinical and aortic remodeling results from the Study for the Treatment of complicated Type B Aortic Dissection using Endoluminal repair (STABLE) trial, a prospective, multicenter study evaluating safety and effectiveness of a pathology-specific endovascular system (proximal stent graft and distal bare metal stent) for the treatment of complicated type B aortic dissection. Methods All 86 enrolled patients (mean age, 59 years; 73.3% men) were treated within 90 days of symptom onset (55 with acute dissections and 31 with nonacute dissections). Inclusion criteria were branch vessel obstruction/compromise, impending rupture as evidenced by periaortic effusion/hematoma, resistant hypertension, persistent pain/symptoms, or aortic growth ≥5 mm within 3 months (or transaortic diameter ≥40 mm). Remodeling of the dissected aorta, including thrombosis of the false lumen and changes in the true lumen, false lumen, and transaortic diameter, were assessed in patients with available computed tomographic imaging through 2 years. Results The 30-day mortality rate was 4.7% (4/86) in the overall patient group (5.5% in acute patients and 3.2% in non-acute patients). Freedom from all-cause mortality was 88.3% at 1 year and 84.7% at 2 years (no significant difference between acute and nonacute patients). From baseline to 2 years, the true lumen diameter increased significantly in the descending thoracic aorta and the more distal abdominal aorta, along with a decrease in the false lumen diameter in both aortic segments. A majority of patients had either a stable or shrinking transaortic diameter in the thoracic (80.3% at 1 year and 73.9% at 2 years) or abdominal aorta (79.1% at 1 year and 66.7% at 2 years). Transaortic growth (>5 mm) occurred predominantly in acute dissections. Consistently, a shorter time from symptom onset to treatment was found to predict transaortic growth in the abdominal aorta (P =.03). Conclusions Endovascular repair of complicated type B aortic dissection with the use of a composite construct demonstrates favorable early clinical outcomes and aortic remodeling. However, patients treated in the acute setting may be prone to aortic growth and may require close observation. Follow-up through 5 years is ongoing.

UR - http://www.scopus.com/inward/record.url?scp=84900793509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900793509&partnerID=8YFLogxK

U2 - 10.1016/j.jvs.2013.12.038

DO - 10.1016/j.jvs.2013.12.038

M3 - Article

VL - 59

SP - 1544

EP - 1554

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 6

ER -